Fertility Preservation

An estimated 18.1 million cancer survivors live in the United States, according to American Cancer Society.

In this video exclusive, Caroline T. Nguyen, MD, talks with Zaraq Khan, MBBS, MS, FACOG, about fertility preservation options for transgender patients.

ANAHEIM, Calif. — In this video exclusive, Francesca Barrett, MD, MBA, discusses concerns with fertility preservation and posthumous use of assisted reproductive technologies for adolescents and young adults with poor cancer prognoses.

Fertility preservation did not appear associated with an increased risk for breast cancer recurrence or disease-specific mortality among a cohort of young women diagnosed with breast cancer, according to study results.

The overturning of Roe v. Wade earlier this year may limit or prevent access altogether to fertility preservation for more than 32,000 adolescents and young adults who were newly diagnosed with cancer.

Women diagnosed with breast or gynecologic cancers underutilized both assisted reproductive technology and fertility-sparing oncology care, according to study results.

Patients are using crowdfunding to raise money for infertility care resulting from a variety of medical conditions, according to a retrospective study presented at the ASRM Scientific Congress & Expo.

Fertility preservation after breast cancer diagnosis led to short delays in time to treatment, according to results of a retrospective cohort study published in Cancer.

Women with germline BRCA mutations have lower levels of anti-Müllerian hormone than women without these mutations, according to results of a meta-analysis published in Journal of Clinical Oncology.

Women with early cervical cancer who conceived at least 3 months after fertility-sparing surgery had a high live birth rate, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.